256 related articles for article (PubMed ID: 22634086)
21. Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods.
Metcalfe P; Williamson LM; Reutelingsperger CP; Swann I; Ouwehand WH; Goodall AH
Br J Haematol; 1997 Jul; 98(1):86-95. PubMed ID: 9233569
[TBL] [Abstract][Full Text] [Related]
22. Quality assessment of platelets stored in a modified platelet additive solution with trehalose at low temperature (10 °C) and in vivo effects on rabbit model of thrombocytopenia.
Wang X; Fan Y; Shi R; Li J; Zhao S
Platelets; 2015; 26(1):72-9. PubMed ID: 24499059
[TBL] [Abstract][Full Text] [Related]
23. Platelet storage in more than 90% additive solution containing glucose and bicarbonate has the potential to increase shelf life.
Bashir S; Kemsley K; Min K; Swann ID; Cardigan R
Transfusion; 2018 Dec; 58(12):2959-2968. PubMed ID: 30265746
[TBL] [Abstract][Full Text] [Related]
24. [Activation of random-donor platelet concentrates and platelet prepared from random-donor apheresis collections during storage].
Lin JJ; Fan HH; Ma Q; Feng ML; Shen XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Oct; 10(5):458-61. PubMed ID: 12513749
[TBL] [Abstract][Full Text] [Related]
25. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
Moog R; Fröhlich A; Mayaudon V; Lin L
J Clin Apher; 2004; 19(4):185-91. PubMed ID: 15597347
[TBL] [Abstract][Full Text] [Related]
26. Quality of irradiated and non-irradiated plateletpheresis concentrates stored in platelet additive solution.
Moog R; Rothe R; Arlt N; Burkhardt T
Transfus Apher Sci; 2018 Apr; 57(2):228-232. PubMed ID: 29482968
[TBL] [Abstract][Full Text] [Related]
27. In vitro thrombus formation and in vivo hemostasis mediated by platelets irradiated with bactericidal ultraviolet C from xenon flash under flow conditions.
Abe H; Endo K; Nogawa M; Shiba M; Miyata S; Satake M
Transfusion; 2021 Jan; 61(1):191-201. PubMed ID: 33107611
[TBL] [Abstract][Full Text] [Related]
28. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the platelet activation status of single-donor platelets obtained with two different cell separator technologies.
Millar D; Hayes C; Jones J; Klapper E; Kniep JN; Luu HS; Noland DK; Petitti L; Poisson JL; Spaepen E; Ye Z; Maurer-Spurej E
Transfusion; 2020 Sep; 60(9):2067-2078. PubMed ID: 32729161
[TBL] [Abstract][Full Text] [Related]
30. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
[TBL] [Abstract][Full Text] [Related]
31. Comparison of soluble CD40L concentrations and release capacities in apheresis and prestorage pooled platelet concentrates.
Wenzel F; Günther W; Baertl A; Lasshofer R; Rox J; Fischer JC; Giers G
Clin Hemorheol Microcirc; 2011; 47(4):269-78. PubMed ID: 21654056
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of the Physiological Activities and Functions in Vitro of Apheresis Platelets during Storage].
Xu HM; Zhao DY; Hao YW; Gao NN; Cui JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):856-60. PubMed ID: 26117050
[TBL] [Abstract][Full Text] [Related]
33. In vitro quality and platelet function of cold and delayed cold storage of apheresis platelet concentrates in platelet additive solution for 21 days.
Braathen H; Sivertsen J; Lunde THF; Kristoffersen EK; Assmus J; Hervig TA; Strandenes G; Apelseth TO
Transfusion; 2019 Aug; 59(8):2652-2661. PubMed ID: 31150571
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of store lesion in platelet obtained by apheresis compared to platelet derived from whole blood and its impact on the in vitro functionality.
Quintero M; Núñez M; Mellado S; Maldonado M; Wehinger S
Transfus Apher Sci; 2015 Dec; 53(3):293-9. PubMed ID: 26043812
[TBL] [Abstract][Full Text] [Related]
35. Seven-day storage of apheresis platelets: report of an in vitro study.
Dumont LJ; VandenBroeke T
Transfusion; 2003 Feb; 43(2):143-50. PubMed ID: 12559008
[TBL] [Abstract][Full Text] [Related]
36. Storage of platelets in additive solutions: effects of phosphate.
Gulliksson H; Larsson S; Kumlien G; Shanwell A
Vox Sang; 2000; 78(3):176-84. PubMed ID: 10838519
[TBL] [Abstract][Full Text] [Related]
37. Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days.
Albanyan AM; Harrison P; Murphy MF
Transfusion; 2009 Jan; 49(1):108-17. PubMed ID: 18954396
[TBL] [Abstract][Full Text] [Related]
38. Microparticle content of platelet concentrates is predicted by donor microparticles and is altered by production methods and stress.
Maurer-Spurej E; Larsen R; Labrie A; Heaton A; Chipperfield K
Transfus Apher Sci; 2016 Aug; 55(1):35-43. PubMed ID: 27470708
[TBL] [Abstract][Full Text] [Related]
39. Phosphatidylserine exposure in platelet concentrates during the storage period: differences between the platelets collected with different cell separators.
Lai M; Rumi C; D'Onofrio G; Puggioni PL; Menichella G; Candido A; Leone G
Transfus Apher Sci; 2002 Dec; 27(3):239-45. PubMed ID: 12509219
[TBL] [Abstract][Full Text] [Related]
40. Platelets stored in a new-generation container differences between plasma and platelet additive solution II.
de Wildt-Eggen J; Schrijver JG; Smid WM; Joie M; Bollinne V; Bins M
Vox Sang; 1998; 75(3):218-23. PubMed ID: 9852410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
